Navigation Links
Soligenix Announces Appointment of Marco Maria Brughera to its Board of Directors
Date:10/21/2013

PRINCETON, N.J., Oct. 21, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense medical countermeasures where there remains an unmet medical need, announced today the appointment of Marco Maria Brughera, DVM, Global Head of the Rare Disease Franchise for Sigma-Tau SpA, to its Board of Directors. 

"We are pleased to welcome Dr. Brughera to the Soligenix Board," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "As Soligenix looks to advance its pipeline, we intend to leverage Dr. Brughera's extensive experience in research and development, portfolio optimization and business development. We believe his outstanding record of achievement will add significantly to our already diverse and experienced Board of Directors and management team.  We look forward to his contributions to our future success, particularly as we move forward with our infectious disease and biodefense programs, including the development of OrbeShield™ in GI ARS under our recent BARDA and NIAID contract awards of up to $26.3M and $6.4M, respectively."

Since January 2011, Dr. Brughera has held several positions for the Sigma-Tau Group, including Corporate Research and Development Managing Director of Sigma-Tau SpA, President of Sigma-Tau Research and Board Member of Sigma-Tau Pharmaceuticals.  From 2004 to 2010, Dr. Brughera served as the Vice President of Preclinical Development at Nerviano Medical Sciences (NMS), a pharmaceutical oncology-focused integrated discovery and development company.  He also served as the Managing Director at Accelera, an independent contract research organization with the NMS Group.  From 1999 to 2004, Dr. Brughera held several senior level positions i
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Soligenix to Present at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City
2. Soligenix Reports Second Quarter 2013 Financial Results, and Highlights Recent Accomplishments
3. Soligenix Announces Pricing of Public Offering of Common Stock and Warrants
4. FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer
5. Soligenix Initiates Phase 1 Clinical Study with SGX203 for the Treatment of Pediatric Crohns Disease
6. Soligenix Reports First Quarter 2013 Financial Results and Highlights Recent Accomplishments
7. Soligenix and Intrexon Pursue Melioidosis Therapy Through Worldwide Exclusive Collaboration
8. Soligenix to Present at World Vaccine Congress & Expo
9. Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis
10. Soligenix to Present at 15th Annual BIO CEO & Investor Conference
11. Soligenix Announces Formation of Oral Mucositis Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 24, 2014 Best Practices designed the ... with a forum for sharing insights about the ... a mechanism for creating and sharing solutions through ... findings from the Medical Affairs Consortium survey. ... for the first roundtable of the 2014-2015 Medical ...
(Date:10/22/2014)... SANTA CLARA, Calif. , Oct. 22, 2014 /PRNewswire/ ... today announced the introduction of the cQUB™-1 (cQuest Ultrasound ... cQUB white-label ultrasound systems designed and manufactured by Cephasonics ... brand name and model number. Cephasonics will be showcasing ... 2014 being held this week in Chongqing, ...
(Date:10/22/2014)... 2014 Investor-Edge has initiated coverage ... FOLD ), Progenics Pharmaceuticals Inc. (NASDAQ: ... ), Idera Pharmaceuticals Inc. (NASDAQ: IDRA ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,419.48, up 2.40%, the Dow ...
Breaking Medicine Technology:Strong Participation in Best Practices' Medical Affairs Consortium Survey 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 2Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 3Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 4Market Momentum on Biotech Stocks - Amicus Therapeutics, Progenics Pharma, Threshold Pharma, Idera Pharma, and Merrimack Pharma 5
... SAN DIEGO, Feb. 16, 2012  Cardium Therapeutics (NYSE Amex: ... completed the previously announced sale of 17,857,143 shares of ... gross proceeds of approximately $5.0 million, before deducting placement ... and accredited investors participating in the offering purchased the ...
... Bionovo, Inc. (OTC Link Platform: BNVI.PK) a pharmaceutical company ... effective treatments for women,s health and cancer, announced today ... February 21, 2012 at 1:30 PM PST to discuss ... 31, 2011. (Logo:  http://photos.prnewswire.com/prnh/20111110/SF04662LOGO ) ...
Cached Medicine Technology:Cardium Announces Closing of $5.0 Million Equity Financing 2Cardium Announces Closing of $5.0 Million Equity Financing 3
(Date:10/25/2014)... Oct. 25, 2014 (HealthDay News) -- Arriving home safe and ... To that end, be sure that costumes and goody ... Dr. Sampson Davis, an emergency medicine doctor at Meadowlands Hospital ... carry a flashlight, and costumes should be flame-resistant, Davis said. ... plan to use makeup, test it on a small area ...
(Date:10/25/2014)... 25, 2014 TASC (Total Administrative ... other benefits account management services, announces the release ... save on taxes, reduce administrative workload, and lessen ... savings and the efficient handling of complex, time-sensitive, ... that best meets their goals and objectives. The ...
(Date:10/25/2014)... Oshkosh, Wisconsin (PRWEB) October 25, 2014 ... looking for a great selection at affordable prices. Bob ... Civic Center Huntington Center and Nationwide Arena are going ... quickly. , Click Here to browse the ... Bullet Band at QueenBeeTickets.com. , The famous singer is ...
(Date:10/25/2014)... Raleigh, NC (PRWEB) October 25, 2014 ... patient who continued to receive pemetrexed (Alimta), after his ... to read the full story , just posted on ... study from Uji Tokushukai Medical Center in Japan suggests ... for mesothelioma patients who cannot tolerate higher ...
(Date:10/25/2014)... Steven Reinberg HealthDay Reporter ... that causes common cold sores -- herpes simplex -- might ... researchers suggest. In fact, being a carrier of certain ... disease, the researchers found. "The identification of a ... is a breakthrough," said lead researcher Dr. Hugo Lovheim, an ...
Breaking Medicine News(10 mins):Health News:Tips for Safe Trick-or-Treating 2Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:QueenBeeTickets.com Features Bob Seger & The Silver Bullet Band Tickets for Charleston Civic Center, Huntington Center, and Nationwide Arena at Reduced Prices 2Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3
... during pregnancy can reduce the incidence of pregnancy ... published by American Journal of Obstetrics and Gynecology. ... elevated blood pressure and proteinuria (high levels of ... hands and legs is usually seen. If left ...
... National Institute of Dental and Craniofacial Research, Marquette ... Center for Disease Control, and the National Center ... towards achieving the "Healthy People 2010 Oral Health ... combined meeting of the American Association for Dental ...
... on the sale of the soft drinks stating that it ... round the corner, there is// every possibility of children opting ... drinks has bad affects on the health of schoolchildren, specially ... the sale of these aerated drinks in government-run schools," Ghanshyam ...
... in reducing the bad cholesterol. For example food like oat ... that by combining these food substances one can get the ... they are at a higher risk of getting a heart ... (LDL) as effectively as a commonly prescribed medication. ...
... Smithkline (Britain's biggest drug manufacturer) is being registered for ... vaccine would be marketed for commercial use, by the ... similar vaccine produced by the US pharmaceuticals giant Merck ... It has been proposed to register Cervarix in the ...
... been taken into police custody after a patient died ... named, was hauled up for questioning// after a grandfather ... ,60-year-old Alan Dunn, a resident of Ferryhill, County ... he had apparently stabbed himself was removed from his ...
Cached Medicine News:Health News:Choose Foods That Keep Bad Cholesterol at Bay 2
... Mini Step™ device components are supplied sterile. , ... System is supplied sterile in 2/3, 5, 7/8, ... configurations and combinations. They are used in conjunction ... the Step™ radially Expandable Sleeve. The 5, 7/8, ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
VERSAPORT™ Plus RT Single Use Obturators for use with VERSAPORT™ RT Reusable Cannulae....
... SPRING-GRIP™ single use nonconductive anchoring devices are ... mm and 12 mm sizes for use ... mm, 5 mm-10 mm, 5 mm-11 mm, ... sizes for use with the VERSAPORT™, SURGISPIKE™, ...
Medicine Products: